AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37201751 — intervention group
Group type: EXPERIMENTAL
Intervention: CANKADO-active arm
Number of subjects: 499
Study 37201751 — intervention group
Group type: COMPARATOR
Intervention: CANKADO-inform arm
Number of subjects: 499
Study 37201757 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Accelerated Partial Breast Irradiation (APBI) at 30 Gy in 5 fractions
Number of subjects: 204
Study 37201757 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Accelerated Partial Breast Irradiation (APBI)
Number of subjects: 204
Study 37201757 — intervention group
Group type: COMPARATOR
Intervention: Whole Breast Irradiation (WBI)
Number of subjects: 204
Study 37201756 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative Proton Beam Therapy with Concurrent Chemotherapy
Number of subjects: 0
Study 37201756 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 37201900 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine intravenous therapy (KIT) induction
Number of subjects: 2758
Study 37201900 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine intravenous therapy (KIT) maintenance
Number of subjects: 2758
Study 37201900 — intervention group
Group type: COMPARATOR
Intervention: Ketamine intravenous therapy (KIT) at eight weeks
Number of subjects: 2758
Study 37202039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional therapy received in the first days of intensive care admission
Number of subjects: 103
Study 37202039 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional capacity assessment
Number of subjects: 103
Study 37202039 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality assessment
Number of subjects: 103
Study 37202042 — intervention group
Group type: COMPARATOR
Intervention: ω-3 fatty acid ethyl esters (4 g/day)
Number of subjects: 20
Study 37202059 — intervention group
Group type: EXPERIMENTAL
Intervention: KETO
Number of subjects: 8
Study 37202059 — intervention group
Group type: EXPERIMENTAL
Intervention: EXO
Number of subjects: 8
Study 37202059 — intervention group
Group type: COMPARATOR
Intervention: ISO
Number of subjects: 8
Study 37202059 — intervention group
Group type: COMPARATOR
Intervention: FAST
Number of subjects: 8
Study 37202073 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-elemental enteral formula with partially hydrolyzed guar gum (PHGG) at 12 g/L
Number of subjects: 24
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggested deadline (1 week)
Number of subjects: 40000
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggested deadline (2 weeks)
Number of subjects: 40000
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggested deadline (4 weeks)
Number of subjects: 40000
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning tool
Number of subjects: 40000
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning tool plus suggested deadline (1 week)
Number of subjects: 40000
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning tool plus suggested deadline (2 weeks)
Number of subjects: 40000
Study 37202130 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning tool plus suggested deadline (4 weeks)
Number of subjects: 40000
Study 37202130 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 40000
Study 37202143 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive function evaluation over time
Number of subjects: 0
Study 37202143 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-perceived quality of life and fatigue
Number of subjects: 0
Study 37202143 — intervention group
Group type: EXPERIMENTAL
Intervention: P300 in an electroencephalography (EEG) oddball paradigm
Number of subjects: 0
Study 37202143 — intervention group
Group type: EXPERIMENTAL
Intervention: Power spectrum in resting state EEG
Number of subjects: 0
Study 37202143 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum and cerebrospinal fluid levels of biomarkers of neuronal damage, neuroplasticity, proinflammatory and anti-inflammatory markers
Number of subjects: 0
Study 37202147 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally aerosolized adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV)
Number of subjects: 0
Study 37202152 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon angioplasty plus aggressive medical management (AMM)
Number of subjects: 0
Study 37202152 — intervention group
Group type: COMPARATOR
Intervention: Aggressive medical management (AMM) alone
Number of subjects: 0
Study 37202253 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on umbilical cord care
Number of subjects: 2
Study 37202253 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 2
Study 37202261 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 260
Study 37202447 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets
Number of subjects: 0
Study 37202447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 37202497 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (aerobic and/or strength training)
Number of subjects: 27
Study 37202497 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 27
Study 37202530 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3 supplement (40 mg/kg/day) for 2 weeks
Number of subjects: 70
Study 37202530 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 70
Study 37202647 — intervention group
Group type: EXPERIMENTAL
Intervention: Right-hand opening-closing motor task
Number of subjects: 20
Study 37202647 — intervention group
Group type: EXPERIMENTAL
Intervention: Right shoulder abduction-adduction motor task
Number of subjects: 20
Study 37202781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral scanning using the Emerald (Planmeca) intraoral scanner
Number of subjects: 113
Study 37202813 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (5 mg p.o./day for 2 weeks escalated to 10 mg p.o./day for 6 weeks)
Number of subjects: 15
Study 37202822 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPER (team approach to polypharmacy evaluation and reduction)
Number of subjects: 39
Study 37202822 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 39
Study 37202831 — intervention group
Group type: EXPERIMENTAL
Intervention: CRC evidence-based interventions implemented at health centers
Number of subjects: 12
Study 37202831 — intervention group
Group type: COMPARATOR
Intervention: Matched control health centers (C)
Number of subjects: 12
Study 37202893 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85
Number of subjects: 24
Study 37202893 — intervention group
Group type: COMPARATOR
Intervention: Control (no bacterial lysates)
Number of subjects: 24
Study 37203207 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative 3D endoanal ultrasound (EAUS) at 3 months
Number of subjects: 95
Study 37203207 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of gas in fistula and clinical finding of fluid discharge through the external fistula opening at 3 months
Number of subjects: 95
Study 37203207 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative 3D EAUS at late control (6-12 months)
Number of subjects: 95
Study 37203237 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit2Thrive intervention (core intervention with Fitbit + Fit2Thrive smartphone app)
Number of subjects: 269
Study 37203243 — intervention group
Group type: EXPERIMENTAL
Intervention: TiNO-coated stents
Number of subjects: 1491
Study 37203243 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 1491
Study 37203300 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 257
Study 37203336 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 26
Study 37203336 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 26
Study 37203336 — intervention group
Group type: COMPARATOR
Intervention: Intranasal insulin
Number of subjects: 26
Study 37203351 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful electrical stimulation using four electrodes positioned on the left side according to the three branches of the trigeminal nerve and the greater occipital nerve, randomized stimulation site, repeated 10 times per session, across three sessions (30 trials per site).
Number of subjects: 87
Study 37203392 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosomal microRNA‑4516
Number of subjects: 93
Study 37203392 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosomal microRNA‑203
Number of subjects: 93
Study 37203392 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretory frizzled‑related protein 1 (SFRP1)
Number of subjects: 93
Study 37203392 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with SYNTAX score
Number of subjects: 93
Study 37203392 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with cardiac troponin I (cTnI) and low-density lipoprotein (LDL)
Number of subjects: 93
Study 37203441 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 587
Study 37203441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 587
Study 37203558 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic repair
Number of subjects: 101
Study 37203558 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic repair
Number of subjects: 101
Study 37204076 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong (n=11)
Number of subjects: 24
Study 37204076 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise/Nutrition (n=13)
Number of subjects: 24
Study 37204106 — intervention group
Group type: EXPERIMENTAL
Intervention: INO-3107 administered by intramuscular injection followed by electroporation on weeks 0, 3, 6, and 9.
Number of subjects: 21
Study 37204106 — intervention group
Group type: EXPERIMENTAL
Intervention: INO-3107
Number of subjects: 21
Study 37204144 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 240
Study 37204144 — intervention group
Group type: COMPARATOR
Intervention: Sham TTNS
Number of subjects: 240
Study 37204277 — intervention group
Group type: EXPERIMENTAL
Intervention: Serdexmethylphenidate/Dexmethylphenidate, treated for up to 12 months
Number of subjects: 0
Study 37204336 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interview to patients
Number of subjects: 510
Study 37204336 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interview to patients and caregivers
Number of subjects: 510
Study 37204336 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 510
Study 37204358 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-Day Discharge (SDD) protocol
Number of subjects: 2332
Study 37204358 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-Day Discharge (SDD) group
Number of subjects: 2332
Study 37204358 — intervention group
Group type: COMPARATOR
Intervention: Non-Same-Day Discharge (non-SDD) group
Number of subjects: 2332
Study 37204382 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning-based clustering of echocardiographic variables
Number of subjects: 429
Study 37204382 — intervention group
Group type: COMPARATOR
Intervention: Conventional analysis
Number of subjects: 429
Study 37204382 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision tree based on severity of MR, LV systolic strain <21%, and indexed LA volume >42 mL/m
Number of subjects: 429
Study 37204397 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative Flow Ratio assessment
Number of subjects: 0
Study 37204397 — intervention group
Group type: COMPARATOR
Intervention: Standard assessment methods
Number of subjects: 0
Study 37204411 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone call strategy
Number of subjects: 345
Study 37204411 — intervention group
Group type: COMPARATOR
Intervention: Mail letter strategy
Number of subjects: 345
Study 37204435 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge-driven model
Number of subjects: 3419
Study 37204435 — intervention group
Group type: EXPERIMENTAL
Intervention: Data-driven model
Number of subjects: 3419
Study 37204435 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision tree model
Number of subjects: 3419
Study 37204435 — intervention group
Group type: EXPERIMENTAL
Intervention: A-DOUBLE-SSI risk score
Number of subjects: 3419
Study 37204435 — intervention group
Group type: EXPERIMENTAL
Intervention: Bootstrap internal validation of knowledge-driven model
Number of subjects: 3419
Study 37204443 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid-jugular angle (CJA) measurement
Number of subjects: 105
Study 37204608 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 379
Study 37204631 — intervention group
Group type: EXPERIMENTAL
Intervention: AVT02 alternating with the reference product (Humira)
Number of subjects: 550
Study 37204631 — intervention group
Group type: COMPARATOR
Intervention: Reference product only (Humira)
Number of subjects: 550
Study 37204754 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic items (female participants)
Number of subjects: 330
Study 37204754 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic items (participants with spouses/partners as informants)
Number of subjects: 330
Study 37204754 — intervention group
Group type: EXPERIMENTAL
Intervention: Health items (better cognitive function of the participant)
Number of subjects: 330
Study 37204788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (<120 mm Hg)
Number of subjects: 7918
Study 37204788 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (<140 mm Hg)
Number of subjects: 7918
Study 37204794 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 IU vitamin D3 supplementation
Number of subjects: 546
Study 37204794 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D3 supplementation
Number of subjects: 546
Study 37204794 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D3 supplementation with maternal 25(OH)D < 30 ng/mL
Number of subjects: 546
Study 37204794 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D3 supplementation with maternal 25(OH)D ≥ 30 ng/mL
Number of subjects: 546
Study 37204830 — intervention group
Group type: EXPERIMENTAL
Intervention: iStride gait device
Number of subjects: 5
Study 37204831 — intervention group
Group type: EXPERIMENTAL
Intervention: Work Ability Index (WAI) assessment
Number of subjects: 494
Study 37204831 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative predictors of work ability
Number of subjects: 494
Study 37204831 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive predictors of work ability
Number of subjects: 494
Study 37204838 — intervention group
Group type: EXPERIMENTAL
Intervention: CareConekta app with supportive phone calls, WhatsApp messages, or both when traveling >50 km from the study area for >7 days
Number of subjects: 200
Study 37204838 — intervention group
Group type: COMPARATOR
Intervention: Control arm receiving the app with no additional support
Number of subjects: 200
Study 37204858 — intervention group
Group type: EXPERIMENTAL
Intervention: VR calm room
Number of subjects: 60
Study 37204858 — intervention group
Group type: COMPARATOR
Intervention: Physical calm room
Number of subjects: 60
Study 37204866 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 39
Study 37204866 — intervention group
Group type: EXPERIMENTAL
Intervention: Confluent atrophy, disrupted retrofoveal ellipsoid zone, and choroidal neovascularization
Number of subjects: 39
Study 37204935 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 66
Study 37204935 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 66
Study 37204935 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study 37205012 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiotherapy (PMRT)
Number of subjects: 3116
Study 37205012 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous reconstruction
Number of subjects: 3116
Study 37205012 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-implant (DTI)
Number of subjects: 3116
Study 37205012 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue expander/immediate (TE/I)
Number of subjects: 3116
Study 37205399 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful vesicovaginal fistula repair
Number of subjects: 40
Study 37205399 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative inquiry among key stakeholders
Number of subjects: 40
Study 37205420 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP-001
Number of subjects: 0
Study 37205420 — intervention group
Group type: COMPARATOR
Intervention: ApAP
Number of subjects: 0
Study 37205428 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation and Biopsychosocial Self-Management
Number of subjects: 0
Study 37205428 — intervention group
Group type: COMPARATOR
Intervention: Medical Care
Number of subjects: 0
Study 37205489 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberative engagement process including an introductory session, workbook, facilitated small group deliberative forum, and post-forum survey.
Number of subjects: 680
Study 37205489 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberative engagement process
Number of subjects: 680
Study 37205558 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 40
Study 37205558 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study 37205559 — intervention group
Group type: EXPERIMENTAL
Intervention: Uplifts
Number of subjects: 0
Study 37205559 — intervention group
Group type: EXPERIMENTAL
Intervention: Hassles
Number of subjects: 0
Study 37205569 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media intervention to increase lung cancer screening awareness, knowledge, and uptake
Number of subjects: 0
Study 37205569 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard awareness methods)
Number of subjects: 0
Study 37205592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters (Moderna mRNA-1273, Pfizer-BioNTech BNT162b2, Sanofi CoV2 preS DTM-AS03)
Number of subjects: 0
Study 37205592 — intervention group
Group type: COMPARATOR
Intervention: Prototype/Wildtype Vaccines
Number of subjects: 0
Study 37205666 — intervention group
Group type: EXPERIMENTAL
Intervention: ICG-guided sentinel node (SN) mapping
Number of subjects: 0
Study 37205721 — intervention group
Group type: EXPERIMENTAL
Intervention: IDA1 (ivermectin 150 μg/kg + albendazole 400 mg + diethylcarbamazine 6 mg/kg)
Number of subjects: 574
Study 37205721 — intervention group
Group type: EXPERIMENTAL
Intervention: IDA3 (three consecutive daily doses of IDA)
Number of subjects: 574
Study 37205721 — intervention group
Group type: COMPARATOR
Intervention: IA (ivermectin 150 μg/kg + albendazole 400 mg)
Number of subjects: 574
Study 37205721 — intervention group
Group type: EXPERIMENTAL
Intervention: IDA treatments (both IDA1 and IDA3 combined)
Number of subjects: 574
Study 37205804 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine
Number of subjects: 163
Study 37205804 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 163
Study 37206279 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-0189 as monotherapy and in combination with rituximab
Number of subjects: 0
Study 37206279 — intervention group
Group type: EXPERIMENTAL
Intervention: GS-0189
Number of subjects: 0
Study 37206996 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-STAR (cone-beam computed tomography-guided stereotactic adaptive radiation therapy)
Number of subjects: 7
Study 37206996 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-STAR
Number of subjects: 7
Study 37206996 — intervention group
Group type: COMPARATOR
Intervention: nonadaptive SBRT
Number of subjects: 7
Study 37207143 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanucizumab in combination with mFOLFOX-6 chemotherapy
Number of subjects: 0
Study 37207143 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab (VEGF-A inhibitor) in combination with mFOLFOX-6 chemotherapy
Number of subjects: 0
Study 37207300 — intervention group
Group type: EXPERIMENTAL
Intervention: Switched endocrine therapy (fulvestrant or exemestane) plus ribociclib
Number of subjects: 119
Study 37207300 — intervention group
Group type: COMPARATOR
Intervention: Switched endocrine therapy (fulvestrant or exemestane) plus placebo
Number of subjects: 119
Study 37207306 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (T-DXd)
Number of subjects: 0
Study 37207306 — intervention group
Group type: COMPARATOR
Intervention: Ado-trastuzumab emtansine
Number of subjects: 0
Study 37207382 — intervention group
Group type: EXPERIMENTAL
Intervention: Eteplirsen (30 mg/kg, once-weekly intravenously for 10 weeks, continuing at 30 mg/kg up to 96 weeks)
Number of subjects: 15
Study 37207382 — intervention group
Group type: EXPERIMENTAL
Intervention: Eteplirsen (30 mg/kg)
Number of subjects: 15
Study 37207654 — intervention group
Group type: EXPERIMENTAL
Intervention: tislelizumab-chemotherapy
Number of subjects: 263
Study 37207654 — intervention group
Group type: COMPARATOR
Intervention: placebo-chemotherapy
Number of subjects: 263
Study 37207655 — intervention group
Group type: EXPERIMENTAL
Intervention: PI3K inhibitors (specifically alpelisib)
Number of subjects: 148
Study 37207655 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor organoids
Number of subjects: 148
Study 37207655 — intervention group
Group type: COMPARATOR
Intervention: Site-of-origin samples
Number of subjects: 148
Study 37207788 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 112
Study 37207788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 37207810 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered acupressure for 6 weeks
Number of subjects: 300
Study 37207810 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (usual care for pain management)
Number of subjects: 300
Study 37207924 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BVS) with improved technique
Number of subjects: 2604
Study 37207924 — intervention group
Group type: COMPARATOR
Intervention: Cobalt chromium everolimus-eluting stents (CoCr-EES)
Number of subjects: 2604